In cases of renal hypoperfusion, epithelial cells may be damaged or killed via necrosis or apoptosis
Moreover, the SURMOUNTMMO (tirzepatide, NCT05556512) will assess the impact of the dual GLP-1/GIP RA in cardiovascular outcomes and all-cause mortality for people with obesity (without diabetes) when the REDEFINE-3 study will assess the impact of cagrisema in people with obesity (with and without T2DM) and established cardiovascular disease
The research, funded by a biotech called BlueWater Biosciences, would still need to be confirmed in humans
Summary: Dark stools are not a recognised or common side effect of Ozempic according to MHRA-approved prescribing information
Most common mistake: Classifying 5-Amino-1MQ as a peptide
Combination therapy is possible under physician supervision, with some clinics offering sermorelin plus GHRP peptides for enhanced growth hormone release